First-line docetaxel chemotherapy for castrate-resistant prostate cancer

Tim Robinson; Bernadette Coles; Timothy J. Wilt; Malcolm Mason; Mike Shelley

doi:10.1002/14651858.CD009654.pub2

First-line docetaxel chemotherapy for castrate-resistant prostate cancer

Tim Robinson
, Bernadette Coles
, Timothy J. Wilt
, Malcolm Mason
, Mike Shelley

Medicine - Veteran's Administration Medical Center

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to assess the comparative effectiveness and toxicity of the chemotherapeutic agent docetaxel for the treatment of castrate resistant prostate cancer.

Original language	English (US)
Article number	CD009654
Journal	Cochrane Database of Systematic Reviews
Volume	2013
Issue number	12
DOIs	https://doi.org/10.1002/14651858.CD009654.pub2
State	Published - Dec 30 2013

Bibliographical note

Publisher Copyright:
© 2013 The Cochrane Collaboration.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1002/14651858.CD009654.pub2

Find It

Find It at U of M Libraries

Cite this

@article{574ce4c4398c4031a2ec70995b75bb73,

title = "First-line docetaxel chemotherapy for castrate-resistant prostate cancer",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to assess the comparative effectiveness and toxicity of the chemotherapeutic agent docetaxel for the treatment of castrate resistant prostate cancer.",

author = "Tim Robinson and Bernadette Coles and Wilt, \{Timothy J.\} and Malcolm Mason and Mike Shelley",

note = "Publisher Copyright: {\textcopyright} 2013 The Cochrane Collaboration.",

year = "2013",

month = dec,

day = "30",

doi = "10.1002/14651858.CD009654.pub2",

language = "English (US)",

volume = "2013",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "12",

}

TY - JOUR

T1 - First-line docetaxel chemotherapy for castrate-resistant prostate cancer

AU - Robinson, Tim

AU - Coles, Bernadette

AU - Wilt, Timothy J.

AU - Mason, Malcolm

AU - Shelley, Mike

PY - 2013/12/30

Y1 - 2013/12/30

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to assess the comparative effectiveness and toxicity of the chemotherapeutic agent docetaxel for the treatment of castrate resistant prostate cancer.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to assess the comparative effectiveness and toxicity of the chemotherapeutic agent docetaxel for the treatment of castrate resistant prostate cancer.

UR - https://www.scopus.com/pages/publications/85041501016

UR - https://www.scopus.com/pages/publications/85041501016#tab=citedBy

U2 - 10.1002/14651858.CD009654.pub2

DO - 10.1002/14651858.CD009654.pub2

M3 - Article

AN - SCOPUS:85041501016

SN - 1361-6137

VL - 2013

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 12

M1 - CD009654

ER -

First-line docetaxel chemotherapy for castrate-resistant prostate cancer

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this